Estrella Immunopharma, Inc. Common Stock

ESLANASDAQ • USD
0.33 USD
↘ 0.05 (13.20%)🟢LIVE (AS OF 11:54 AM EST)
🟢Market: OPEN

ESLA is currently priced at $0.33. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (134.7%) and a bearish Death Cross on the long-term moving averages.

Technical & fundamental data as of Nov 16, 2026.

Open?$0.44
High?$0.45
Low?$0.32
Prev. Close?$0.38
Volume?481.7K
Avg. Volume?4.3M
VWAP?$0.36
Rel. Volume?0.11x
Bid / Ask
Bid?$0.35 × 600
Ask?$0.40 × 100
Spread?$0.05
Midpoint?$0.37
Valuation & Ratios
Market Cap?16.7M
Shares Out?43.5M
Float?15.1M
Float %?35.2%
P/E Ratio?N/A
P/B Ratio?-2.25
EPS?-$0.23
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
Employees
N/A
Market Cap
16.7M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2023-10-02
Address
5858 HORTON STREET, SUITE 370
EMERYVILLE, CA 94608
Phone: (510) 318-9098
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
51
Piotroski F-Score?0/9Weak
Altman Z-Score?-53.42Distress
Confidence?54%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?6.14%Elevated
Short Interest?928.9K
Days to Cover?1.0
Free Float15.1M
Avg Daily Volume2.5M
Settlement Date2026-10-30
Financial Health
Current Ratio?0.20Weak
Quick Ratio?0.20Weak
Cash Ratio?0.02Low
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
-2.25CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.7CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
134.7%STRONG▾
ROA?
S&P
3
-548.7%WEAK▾
Cash Flow & Enterprise
FCF?$-9383567
Enterprise Value?$16.6M
Fundamentals ratios updated end of day